Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 17 Jun 2021 for Neoleukin Therapeutics, Inc., €5,097. Read the official filing
Filing timeline
BuySaleCarl Walkey
Insider track record
Disclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Carl Walkey: trading record in brief
This profile gathers the share dealings of Carl Walkey in Neurogene Inc., where the filings describe the role as senior executive. We count 8 filings; the first trade dates from 5 May 2021 and the latest from 16 June 2021.
Every open-market trade on record is a sale: 8 sales worth €54k.
Most recently, on 17 June 2021, the filings show an open-market sale worth €5,097 in Neurogene Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Carl Walkey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
600 shares@ US$10.199.5% of flowCommon StockSEC:0001209191-21-041814:0
650 shares@ US$10.824610.8% of flowCommon StockSEC:0001209191-21-039819:0
600 shares@ US$11.0010.1% of flowCommon StockSEC:0001209191-21-039223:0
600 shares@ US$10.009.2% of flowCommon StockSEC:0001209191-21-038696:0
600 shares@ US$10.009.2% of flowCommon StockSEC:0001209191-21-036057:0
600 shares@ US$10.639.8% of flowCommon StockSEC:0001209191-21-035020:0
1,200 shares@ US$11.0920.5% of flowCommon StockSEC:0001209191-21-032244:0
1,200 shares@ US$11.3021.0% of flowCommon StockSEC:0001209191-21-030654:0
8 of 8 declarations
